Non-Fiction Books:

Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding

Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent
Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!
$172.99
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks

Buy Now, Pay Later with:

4 payments of $43.25 with Afterpay Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 23 Jul - 2 Aug using International Courier

Description

This study develops a detailed description of the successful technology transfer of an invention — the drug-eluting coronary stent — originating in intramural research within the US National Institutes of Health. The history of the commercialization of the invention is used to illustrate a new policy, proposed and explained in this study, for the payment to the government of royalties on the sales of biomedical products developed with substantial public funding provided through indirect as well as direct funding avenues. The proposed policy addresses concerns about the high prices that taxpayers as consumers pay for biomedical products that were developed with funding from the taxpayers as investors. The study explains the theoretical circumstances in which the policy would not adversely affect the appropriate level of R&D investment, and then uses the history of the drug-eluting coronary stent as an example where biomedical R&D is consistent with those circumstances.
Release date Australia
September 8th, 2021
Audience
  • Professional & Vocational
Pages
112
ISBN-13
9781680838206
Product ID
35298595

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Help & options

Filed under...